Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
British Journal of Pharmacology|March 4, 2025
An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosisPierre-Marie Boutanquoi, Lenny Pommerolle, Lucile Dondaine, et al.
Life Science Alliance|October 13, 2023
The coenzyme A precursor pantethine enhances antitumor immunity in sarcomaRichard Miallot, Virginie Millet, Anais Roger, et al.
Cancer Research|February 5, 2009
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signatureEmmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2012
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02)Juliette Thariat, René-Jean Bensadoun, Marie-Christine Etienne-Grimaldi, et al.
Breast Cancer Research : BCR|December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
BMC Cancer|May 4, 2007
Nectin-4 is a new histological and serological tumor associated marker for breast cancerStéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destructionXi Wen Zhao, Ellen M van Beek, Karin Schornagel, et al.
Plos One|January 14, 2014
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profilingStéphanie Cornen, Arnaud Guille, José Adélaïde, et al.
Molecular Oncology|December 20, 2019
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancersFrançois Bertucci, Charlotte Rypens, Pascal Finetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasetsSteven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
British Journal of Pharmacology|March 4, 2025
An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosisPierre-Marie Boutanquoi, Lenny Pommerolle, Lucile Dondaine, et al.
Life Science Alliance|October 13, 2023
The coenzyme A precursor pantethine enhances antitumor immunity in sarcomaRichard Miallot, Virginie Millet, Anais Roger, et al.
Cancer Research|February 5, 2009
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signatureEmmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2012
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02)Juliette Thariat, René-Jean Bensadoun, Marie-Christine Etienne-Grimaldi, et al.
Breast Cancer Research : BCR|December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersPreeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
BMC Cancer|May 4, 2007
Nectin-4 is a new histological and serological tumor associated marker for breast cancerStéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destructionXi Wen Zhao, Ellen M van Beek, Karin Schornagel, et al.
Plos One|January 14, 2014
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profilingStéphanie Cornen, Arnaud Guille, José Adélaïde, et al.
Molecular Oncology|December 20, 2019
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancersFrançois Bertucci, Charlotte Rypens, Pascal Finetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasetsSteven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Pageof 18